Condensed consolidated statements of cash flows

Fourth quarter

 

January-December

2017 *

2018

in € millions

2017 *

2018

*

Represented to present the Specialty Chemicals business as discontinued operations

1,032

952

Net cash and cash equivalents at beginning of period

1,441

1,278

 

 

 

 

 

45

45

Profit for the period

511

455

62

59

Amortization and depreciation

276

239

239

250

Changes in working capital

(105)

(177)

(9)

45

Changes in provisions

(338)

(203)

(44)

(48)

Interest paid

(81)

(89)

(62)

(53)

Income tax paid

(266)

(164)

71

21

Other changes

281

101

302

319

Net cash from operating activities

278

162

(85)

(54)

Capital expenditures

(250)

(160)

(11)

(80)

Acquisitions and divestments net of cash acquired

(39)

(74)

(5,541)

Investment in short-term investments

(5,541)

76

Other changes

5

107

(96)

(5,599)

Net cash from investing activities

(284)

(5,668)

559

(1,340)

Changes from borrowings

585

(922)

(960)

(135)

Dividend paid

(1,184)

(636)

Share repurchase

(160)

(407)

Buy-out of non-controlling interests

(437)

3

Other changes

5

(401)

(1,879)

Net cash from financing activities

(759)

(1,990)

(195)

(7,159)

Net cash used for continuing operations

(765)

(7,496)

442

8,924

Cash flows from discontinued operations

660

8,958

247

1,765

Net change in cash and cash equivalents of continued and discontinued operations

(105)

1,462

(1)

15

Effect of exchange rate changes on cash and cash equivalents

(58)

(8)

1,278

2,732

Net Cash and cash equivalents at December 31

1,278

2,732

Cash flows and net debt

Operating activities in Q4 2018 resulted in an inflow of €319 million (2017: €302 million). This was mainly driven by higher working capital inflow compared with 2017.

Investing activities in Q4 2018 resulted in an outflow of €5,559 million, mainly driven by investment of the cash proceeds for the sale of the Specialty Chemicals business in short-term investments.

At December 31, 2018, net debt was € 5,861 million negative versus €1,951 million positive at year-end 2017. The decrease was mainly driven by the receipt of the cash proceeds for the sale of the Specialty Chemicals business.